Latest Company Strategy News

Page 1 of 6
IPH has opened FY27 with an 8.4% revenue decline and a 13.4% fall in underlying EBITDA, with currency movements only partly explaining the weakness. New CEO Tony O’Malley says restoring organic growth in Australia and New Zealand is now a clear priority.
Victor Sage
Victor Sage
17 Nov 2026
Ventia will consolidate five operating sectors into three and target at least $60 million in annualised cost savings by December 2027. The overhaul comes as deferred telecommunications and energy work weighs on second-half revenue, although FY26 underlying NPATA growth guidance remains 7% to 10%.
Victor Sage
Victor Sage
9 Nov 2026
AVA Risk Group has opened FY27 with A$6.7 million in quarterly bookings and a 1.2 book-to-bill ratio, while acknowledging that FY26 revenue and profitability fell short of expectations. The company is betting that sharper commercial discipline, US expansion and a broader solutions model can turn a large pipeline into more dependable growth.
Victor Sage
Victor Sage
29 Oct 2026
Temple & Webster is holding to its FY27 EBITDA target of $33 million to $40 million even as revenue fell 8% in the first months of the year. The online retailer says reduced discounting is depressing sales but improving contribution margins, while AI, private-label products and brand investment move from testing into rollout.
Logan Eniac
Logan Eniac
23 Oct 2026
Shaver Shop Group Limited (ASX:SSG) delivered record FY2026 sales, gross profit and operating cash flow, but flagged a softer-than-expected start to the new financial year. Transform-U reached $18 million in sales, while supplier logistics issues and promotional timing weighed on early FY2027 trading.
Logan Eniac
Logan Eniac
16 Oct 2026
Cynata Therapeutics has lodged a replacement prospectus for a fully underwritten $913,000 entitlement offer, with the cash earmarked largely for adviser costs, intellectual property maintenance and working capital. The raising gives the biotech a near-term funding bridge, but the prospectus again flags a material uncertainty over its ability to continue as a going concern.
Victor Sage
Victor Sage
12 Oct 2026
Otto Energy delivered a sharp rise in FY26 profit and operating cash flow, but the improvement came alongside falling production, depleted reserves and an unresolved asset monetisation plan. The debt-free oil and gas producer is now weighing a shareholder cash return while pursuing separate strategies for SM 71 and GC 21.
Victor Sage
Victor Sage
18 Sept 2026
Prescient Therapeutics launches a $7 million Share Purchase Plan at an 18.8% discount to fund advancement of its PTX-100 cancer therapy beyond a key 2026 Dose Optimisation Committee review.
Ada Torres
Ada Torres
25 Aug 2026
PlaySide Studios reversed a prior-year loss with a 13% revenue increase to $54.9 million and a 144% jump in net profit to $5.4 million, driven by strong Original IP sales and a strategic cost restructure.
Sophie Babbage
Sophie Babbage
20 Aug 2026
Green Cross Health CEO Rachael Newfield will step down in January 2027 following the sale of the Medical division, paving the way for a new pharmacy-centric leadership role.
Ada Torres
Ada Torres
14 Aug 2026
Taiton Resources has finalised a placement of 1.14 million shares at 7 cents each, including shares and options issued to insiders following shareholder approval.
Maxwell Dee
Maxwell Dee
8 July 2026
Alice Queen Limited has pushed back the closing date for its partially underwritten rights issue to 19 June 2026, giving shareholders more time to subscribe at 0.9 cents per share.
Claire Turing
Claire Turing
9 June 2026

Browse the archive

Full archive